Skip to content
Screener

Pacific Biosciences of California PACB Goodwill And Intangible Asset Impairment

Goodwill And Intangible Asset Impairment at other companies

Azenta logo
AzentaAZTA
$0

Segments

By segment

See full
Reportable Segment$0

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAndIntangibleAssetImpairment.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating Expense:
Research and development23,02222,52942,63051,582
Sales, general and administrative33,39336,17564,54676,343
Impairment charges15,000
Settlement charges15,400
Gain on disposal of assets(45,796)
Amortization of acquired intangible assets8338331,666362,875
Change in fair value of contingent consideration(18,700)

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's goodwill and intangible asset impairment?
Pacific Biosciences of California (PACB) reported goodwill and intangible asset impairment of $0 in Q2 2026.
What does goodwill and intangible asset impairment mean?
This represents a non-cash charge recognized when the carrying value of goodwill or intangible assets exceeds their fair value. It indicates that the expected future economic benefits from previous acquisitions have declined. Frequent or large impairment charges often signal overpayment for past acquisitions or a deterioration in the underlying business performance.

Ask your AI about Pacific Biosciences of California's goodwill and intangible asset impairment.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude